166 related articles for article (PubMed ID: 38050005)
1. Senescent cells in giant cell arteritis display an inflammatory phenotype participating in tissue injury via IL-6-dependent pathways.
Veroutis D; Argyropoulou OD; Goules AV; Kambas K; Palamidas DA; Evangelou K; Havaki S; Polyzou A; Valakos D; Xingi E; Karatza E; Boki KA; Cavazza A; Kittas C; Thanos D; Ricordi C; Marvisi C; Muratore F; Galli E; Croci S; Salvarani C; Gorgoulis VG; Tzioufas AG
Ann Rheum Dis; 2024 Feb; 83(3):342-350. PubMed ID: 38050005
[TBL] [Abstract][Full Text] [Related]
2. NKG2D stimulated T-cell autoreactivity in giant cell arteritis and polymyalgia rheumatica.
Dejaco C; Duftner C; Al-Massad J; Wagner AD; Park JK; Fessler J; Aigelsreiter A; Hafner F; Vega S; Sterlacci W; Grubeck-Loebenstein B; Tzankov A; Ness T; Boiardi L; Salvarani C; Schirmer M
Ann Rheum Dis; 2013 Nov; 72(11):1852-9. PubMed ID: 23417963
[TBL] [Abstract][Full Text] [Related]
3. Aberrant phenotype of circulating antigen presenting cells in giant cell arteritis and polymyalgia rheumatica.
Reitsema RD; Hesselink BC; Abdulahad WH; van der Geest KSM; Brouwer E; Heeringa P; van Sleen Y
Front Immunol; 2023; 14():1201575. PubMed ID: 37600779
[TBL] [Abstract][Full Text] [Related]
4. The spectrum of giant cell arteritis and polymyalgia rheumatica: revisiting the concept of the disease.
Dejaco C; Duftner C; Buttgereit F; Matteson EL; Dasgupta B
Rheumatology (Oxford); 2017 Apr; 56(4):506-515. PubMed ID: 27481272
[TBL] [Abstract][Full Text] [Related]
5. IL-6 promoter polymorphism at position -174 modulates the phenotypic expression of polymyalgia rheumatica in biopsy-proven giant cell arteritis.
Gonzalez-Gay MA; Hajeer AH; Dababneh A; Garcia-Porrua C; Mattey DL; Amoli MM; Thomson W; Ollier WE
Clin Exp Rheumatol; 2002; 20(2):179-84. PubMed ID: 12051396
[TBL] [Abstract][Full Text] [Related]
6. Serum markers associated with disease activity in giant cell arteritis and polymyalgia rheumatica.
van der Geest KS; Abdulahad WH; Rutgers A; Horst G; Bijzet J; Arends S; Roffel MP; Boots AM; Brouwer E
Rheumatology (Oxford); 2015 Aug; 54(8):1397-402. PubMed ID: 25724206
[TBL] [Abstract][Full Text] [Related]
7. Polymyalgia rheumatica in biopsy proven giant cell arteritis does not constitute a different subset but differs from isolated polymyalgia rheumatica.
González-Gay MA; García-Porrúa C; Vázquez-Caruncho M
J Rheumatol; 1998 Sep; 25(9):1750-5. PubMed ID: 9733456
[TBL] [Abstract][Full Text] [Related]
8. Indication of Activated Senescence Pathways in the Temporal Arteries of Patients With Giant Cell Arteritis.
Jiemy WF; van Sleen Y; Graver JC; Pringle S; Brouwer E; van der Geest KSM; Cornec D; Boots AMH; Sandovici M
Arthritis Rheumatol; 2023 Oct; 75(10):1812-1818. PubMed ID: 37057491
[TBL] [Abstract][Full Text] [Related]
9. Leukocyte Dynamics Reveal a Persistent Myeloid Dominance in Giant Cell Arteritis and Polymyalgia Rheumatica.
van Sleen Y; Graver JC; Abdulahad WH; van der Geest KSM; Boots AMH; Sandovici M; Brouwer E
Front Immunol; 2019; 10():1981. PubMed ID: 31507597
[TBL] [Abstract][Full Text] [Related]
10. Involvement of Monocyte Subsets in the Immunopathology of Giant Cell Arteritis.
van Sleen Y; Wang Q; van der Geest KSM; Westra J; Abdulahad WH; Heeringa P; Boots AMH; Brouwer E
Sci Rep; 2017 Jul; 7(1):6553. PubMed ID: 28747747
[TBL] [Abstract][Full Text] [Related]
11. Disturbed B cell homeostasis in newly diagnosed giant cell arteritis and polymyalgia rheumatica.
van der Geest KS; Abdulahad WH; Chalan P; Rutgers A; Horst G; Huitema MG; Roffel MP; Roozendaal C; Kluin PM; Bos NA; Boots AM; Brouwer E
Arthritis Rheumatol; 2014 Jul; 66(7):1927-38. PubMed ID: 24623536
[TBL] [Abstract][Full Text] [Related]
12. Risk of venous and arterial thromboembolism in patients with giant cell arteritis and/or polymyalgia rheumatica: A Veterans Health Administration population-based study in the United States.
Michailidou D; Zhang T; Stamatis P; Ng B
J Intern Med; 2022 May; 291(5):665-675. PubMed ID: 34982490
[TBL] [Abstract][Full Text] [Related]
13. Development of Giant Cell Arteritis after Treating Polymyalgia or Peripheral Arthritis: A Retrospective Case-control Study.
Liozon E; de Boysson H; Dalmay F; Gondran G; Bezanahary H; Fauchais AL; Ly KH
J Rheumatol; 2018 May; 45(5):678-685. PubMed ID: 29545449
[TBL] [Abstract][Full Text] [Related]
14. Polymyalgia rheumatica and giant cell arteritis-three challenges-consequences of the vasculitis process, osteoporosis, and malignancy: A prospective cohort study protocol.
Emamifar A; Hess S; Gerke O; Hermann AP; Laustrup H; Hansen PS; Thye-Rønn P; Marcussen N; Svendstrup F; Gildberg-Mortensen R; Bang JC; Farahani ZA; Chrysidis S; Toftegaard P; Andreasen RA; le Greves S; Andersen HR; Olsen RN; Hansen IMJ
Medicine (Baltimore); 2017 Jun; 96(26):e7297. PubMed ID: 28658131
[TBL] [Abstract][Full Text] [Related]
15. Differences in clinical manifestations and prognosis of Chinese giant cell arteritis patients with or without polymyalgia rheumatica.
Zhang Y; Wang D; Chu X; Zhang W; Zeng X
Ir J Med Sci; 2019 May; 188(2):713-720. PubMed ID: 30251177
[TBL] [Abstract][Full Text] [Related]
16. Neutrophil extracellular traps in giant cell arteritis biopsies: presentation, localization and co-expression with inflammatory cytokines.
Palamidas DA; Argyropoulou OD; Georgantzoglou N; Karatza E; Xingi E; Kapsogeorgou EK; Anagnostopoulos CD; Lazaris AC; Ritis K; Goules AV; Kambas K; Tzioufas AG
Rheumatology (Oxford); 2022 Apr; 61(4):1639-1644. PubMed ID: 34260696
[TBL] [Abstract][Full Text] [Related]
17. Polymyalgia Rheumatica and Giant Cell Arteritis: A Systematic Review.
Buttgereit F; Dejaco C; Matteson EL; Dasgupta B
JAMA; 2016 Jun; 315(22):2442-58. PubMed ID: 27299619
[TBL] [Abstract][Full Text] [Related]
18. Association of the CXCL9-CXCR3 and CXCL13-CXCR5 axes with B-cell trafficking in giant cell arteritis and polymyalgia rheumatica.
Graver JC; Abdulahad W; van der Geest KSM; Heeringa P; Boots AMH; Brouwer E; Sandovici M
J Autoimmun; 2021 Sep; 123():102684. PubMed ID: 34237649
[TBL] [Abstract][Full Text] [Related]
19. Polymyalgia rheumatica and giant cell arteritis in older patients: diagnosis and pharmacological management.
Schmidt J; Warrington KJ
Drugs Aging; 2011 Aug; 28(8):651-66. PubMed ID: 21812500
[TBL] [Abstract][Full Text] [Related]
20. Altered Plasma Levels and Tissue Expression of Fibroblast Activation Protein Alpha in Giant Cell Arteritis.
Xu S; Jiemy WF; Boots AMH; Arends S; van Sleen Y; Nienhuis PH; van der Geest KSM; Heeringa P; Brouwer E; Sandovici M
Arthritis Care Res (Hoboken); 2024 Apr; ():. PubMed ID: 38685696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
